Your browser doesn't support javascript.
loading
The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder.
McIntyre, Roger S; Patel, Mehul D; Masand, Prakash S; Harrington, Amanda; Gillard, Patrick; McElroy, Susan L; Sullivan, Kate; Montano, C Brendan; Brown, T Michelle; Nelson, Lauren; Jain, Rakesh.
Afiliação
  • McIntyre RS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada.
  • Patel MD; AbbVie, Madison, NJ, USA.
  • Masand PS; Global Medical Education, New York, NY, USA.
  • Harrington A; AbbVie, Irvine, CA, USA.
  • Gillard P; AbbVie, Irvine, CA, USA.
  • McElroy SL; Lindner Center of HOPE, Mason, OH, USA.
  • Sullivan K; College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
  • Montano CB; Knoxville Behavioral & Mental Health Services, Knoxville, TN, USA.
  • Brown TM; CT Clinical Research, Cromwell, CT, USA.
  • Nelson L; RTI Health Solutions, Triangle Park, NC, USA.
  • Jain R; RTI Health Solutions, Triangle Park, NC, USA.
Curr Med Res Opin ; 37(1): 135-144, 2021 01.
Article em En | MEDLINE | ID: mdl-33300813
OBJECTIVE: Depressive episodes and symptoms of bipolar I disorder are commonly misdiagnosed as major depressive disorder (MDD) in primary care. The novel and pragmatic Rapid Mood Screener (RMS) was developed to screen for manic symptoms and bipolar I disorder features (e.g. age of depression onset) to address this unmet clinical need. METHODS: A targeted literature search was conducted to select concepts thought to differentiate bipolar I from MDD and screener tool items were drafted. Items were tested and refined in cognitive debriefing interviews with individuals with self-reported bipolar I or MDD (n = 12). An observational study was conducted to evaluate predictive validity. Participants with clinical interview-confirmed bipolar I or MDD diagnoses (n = 139) completed a draft 10-item screening tool and other questionnaires. Data were analyzed to identify the smallest possible subset of items with optimized sensitivity and specificity. RESULTS: Adults with confirmed bipolar I (n = 67) or MDD (n = 72) participated in the observational study. Ten draft screening tool items were reduced to 6 final RMS items based on the item-level analysis. When 4 or more items of the RMS were endorsed ("yes"), sensitivity was 0.88 and specificity was 0.80; positive and negative predictive values were 0.80 and 0.88, respectively. These properties were an improvement over the Mood Disorder Questionnaire in the same analysis sample while using 60% fewer items. CONCLUSION: The pragmatic 6-item RMS differentiates bipolar I disorder from MDD in patients with depressive symptoms, providing real-world guidance to primary care practitioners on whether a more comprehensive assessment for bipolar I disorder is warranted.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Inquéritos e Questionários Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Inquéritos e Questionários Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article